|Articles|January 29, 2021
Top questions answered on challenging HCP assays
Author(s)Cytiva
Cytiva experts answer your top questions about challenging host cell protein assays to improve risk mitigation.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
China Approves First Monthly Biologic for COPD
2
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
3
FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences
4
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
5